484 related articles for article (PubMed ID: 22498364)
1. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
[TBL] [Abstract][Full Text] [Related]
2. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
3. SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA.
Beavogui AH; Diawara EY; Cherif MS; Delamou A; Diallo N; Traore A; Millimouno P; Camara D; Sylla MM; Toure AA; Diallo MS; Toure S; Togo A; Camara G; Kourouma K; Sagara I; Dicko A; Djimde A
J Parasitol; 2021 Sep; 107(5):778-782. PubMed ID: 34581793
[TBL] [Abstract][Full Text] [Related]
4. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
[TBL] [Abstract][Full Text] [Related]
7. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
9. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S
Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992
[TBL] [Abstract][Full Text] [Related]
10. Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.
Fröberg G; Jörnhagen L; Morris U; Shakely D; Msellem MI; Gil JP; Björkman A; Mårtensson A
Malar J; 2012 Sep; 11():321. PubMed ID: 22966778
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
[TBL] [Abstract][Full Text] [Related]
12. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
[TBL] [Abstract][Full Text] [Related]
13. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.
Folarin OA; Bustamante C; Gbotosho GO; Sowunmi A; Zalis MG; Oduola AM; Happi CT
Acta Trop; 2011 Dec; 120(3):224-30. PubMed ID: 21920347
[TBL] [Abstract][Full Text] [Related]
14. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
15. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
16. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
[TBL] [Abstract][Full Text] [Related]
17. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
[TBL] [Abstract][Full Text] [Related]
18. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
[TBL] [Abstract][Full Text] [Related]
19. Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Acta Trop; 2015 Sep; 149():59-63. PubMed ID: 26001972
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
